Luvo Health review
Luvo Health is the rare provider that publishes its whole price list — every program, every plan length — before asking you for anything, and then sells almost everything: semaglutide as an injection at $249 or tablets at $279, tirzepatide at $339, a genuine low-dose microdosing tier at $179 for either molecule, and real FDA-approved Ozempic and Zepbound at $1,299 and $1,399 for anyone who wants the on-label product. Twelve-week plans bring the injections down to about $219 and $309 a month. Its LegitScript certification is real — the seal ID returns a live image where an invented one errors — and it commits to not charging you if a clinician decides you aren't eligible. Two things hold it back. It never names the pharmacy that compounds any of this, which is a step behind the providers that do. And its own affiliate program is registered as a peptides and longevity offer that lands on a NAD+ and sermorelin page by default, so the weight-loss side of the business is the part it markets least.
Every medical claim in this piece is footnoted to the record it came from — the trial or the FDA label — so you can read the source rather than take the masthead's word for it. No one on this desk is your clinician.
Luvo Health at a glance
- Semaglutide
- $249/mo
- Tirzepatide
- $339/mo
- Coverage
- 50 states (as advertised)
- Brand-name
- Yes
How we scored Luvo Health
Each score comes out of Luvo Health's published pricing, disclosures and oversight, and the six combine into the 73/100 Editors' Rating on the same weighted six-factor framework we apply to every provider — never nudged by whether a provider pays us.
Cost is unpredictable, premium, or hides behind a plan commitment.
Oversight and lab support fall short of the top of this roster — the review below says exactly where.
Publishes a real, all-in monthly number before you hand over your history.
Little here is shaped around a mother's week or her life stage.
Standard support — enough to stay on track, not high-touch.
Leaving costs you — notice windows, minimum terms or fees you don't get back.
How we verified this review
- Last verified
- August 2026
- Confidence
- high
- Primary source
- www.luvohealth.com/pricing
$249 and $339 on the four-week column, with tablets at $279 and a microdose track at $179, and twelve-week pricing published alongside. No compounding pharmacy is named anywhere, only 'licensed pharmacies'. Ignore the '$10/week' beside each row — it is a financing artifact of the template rather than a price.
Pricing
Prices re-verified
| Medication | Monthly | Plan |
|---|---|---|
| Compounded semaglutide | $249 | Semaglutide InjectionThe month-to-month rate for the weekly shot on Luvo's own published pricing table. Twelve weeks costs $657, which works out to $219/mo. |
| Compounded tirzepatide | $339 | Tirzepatide InjectionMonth-to-month tirzepatide. Twelve weeks is $927, or about $309/mo — the discount for committing is real but modest. |
| Oral semaglutide | $279 | Semaglutide TabletsAn oral tablet rather than an injection, and priced $30 above the shot — the opposite of how most providers price the two. |
| Compounded tirzepatide | $179 | Microdosing Tirzepatide InjectionA genuine low-dose tier at nearly half the standard tirzepatide price. Microdosing is a marketing term, not a proven protocol — treat it as a slower titration. |
| Brand tirzepatide | $1399 | Zepbound (brand-name)Genuine FDA-approved Zepbound at a cash price, on the same platform as the compounded options. |
| Brand semaglutide | $1299 | Ozempic (brand-name)Cash-pay brand Ozempic. Luvo says some services may support insurance workflows, but the GLP-1 line is priced as cash-pay. |
Swipe the table to see plan details →
GLP-1 telehealth is usually HSA- and FSA-eligible, so check your own plan. Everything above comes from Luvo Health's public disclosures at last review and change often; confirm the current number on Luvo Health's own site.
What we like
- Publishes a full price list by program before any intake, including the 12-week rates
- Both molecules as injections plus semaglutide tablets, and genuine brand Ozempic and Zepbound on the same platform
- A real low-dose microdosing tier at $179 for either molecule — nearly half the standard tirzepatide price
- LegitScript seal independently confirmed genuine against an invented-ID control
- Not charged if a clinician finds you aren't eligible, and you can pause or cancel from the account
The caveats
- Its affiliate program is registered as a peptides and longevity offer that defaults to a NAD+ and sermorelin page, so the weight-loss route has to be linked deliberately
- No compounding pharmacy is named anywhere — only 'licensed pharmacies'
- Semaglutide tablets cost $30 more than the injection, the opposite of how most providers price the oral form
- Refunds depend on whether a prescription has already been filled or shipped, which is a narrow window once a subscription renews
- Claims 50 states served but publishes no state list and names no individual clinician
- No postpartum, breastfeeding or PCOS guidance anywhere on the site
Luvo Health for mothers: our verdict
Luvo Health is the rare provider that publishes its whole price list — every program, every plan length — before asking you for anything, and then sells almost everything: semaglutide as an injection at $249 or tablets at $279, tirzepatide at $339, a genuine low-dose microdosing tier at $179 for either molecule, and real FDA-approved Ozempic and Zepbound at $1,299 and $1,399 for anyone who wants the on-label product. Twelve-week plans bring the injections down to about $219 and $309 a month. Its LegitScript certification is real — the seal ID returns a live image where an invented one errors — and it commits to not charging you if a clinician decides you aren't eligible. Two things hold it back. It never names the pharmacy that compounds any of this, which is a step behind the providers that do. And its own affiliate program is registered as a peptides and longevity offer that lands on a NAD+ and sermorelin page by default, so the weight-loss side of the business is the part it markets least. It runs about $249/month, flat across every dose — a premium to the category, so the extras have to earn it.
We weigh Luvo Health the way mothers actually have to: not just the real monthly cost, but the real monthly cost once the dose climbs and whether a real clinician stands behind it — the things a generic roundup never gets to.
What Luvo Health actually costs
- Compounded semaglutide — Semaglutide Injection: $249/mo
- Compounded tirzepatide — Tirzepatide Injection: $339/mo
- Oral semaglutide — Semaglutide Tablets: $279/mo
- Compounded tirzepatide — Microdosing Tirzepatide Injection: $179/mo
- Brand-name tirzepatide — Zepbound (brand-name): $1399/mo
- Brand-name semaglutide — Ozempic (brand-name): $1299/mo
For context, the typical ongoing price across our roster is around $179/month, so Luvo Health sits at the premium end.
The medications Luvo Health prescribes
Luvo Health prescribes semaglutide and tirzepatide — the pair with the strongest evidence behind them, and having both under one account matters when insulin resistance, familiar from PCOS and gestational diabetes, makes tirzepatide the better fit. It can also route you to FDA-approved brand pens rather than only compounded vials, and those carry the manufacturer's own pregnancy and lactation labeling, which is a cleaner document to take to an OB.
A needle-free oral or sublingual option is on the menu, which draws in mothers who've been avoiding injections — just set expectations: oral and buccal delivery of these peptides is far less studied than the injectable versions the trials used.
Where Luvo Health fits — and where it doesn't — for mothers
Worth it if…
- you want a real clinician reading your history around the real monthly cost once the dose climbs, not an auto-approving quiz.
- you may need to move between semaglutide and tirzepatide as your body and hormones change.
Give it a miss if…
- you'd rather a prescriber talk through timing around the real monthly cost once the dose climbs — that's what our #1 pick, CoreAge Rx, is built for.
Trust, safety, and oversight
Our confidence in Luvo Health's public facts is high — pricing, pharmacies, and clinical network were verifiable at last review. As with any compounded GLP-1, the most useful thing mothers can do is confirm which licensed pharmacy fills the prescription and what's in the formulation — we explain how we weigh oversight in our Editors' Rating methodology.
One line that applies to every provider on this masthead: no GLP-1 is established as safe in pregnancy or while breastfeeding, and the labels advise against use. This is a review of a commercial program, not a green light — the timing decision belongs to you and your clinician.
The bottom line
Luvo Health is a reasonable option — weigh it on the real monthly cost once the dose climbs and whether a real clinician stands behind it against the alternatives below. For most mothers, CoreAge Rx remains the stronger all-round fit — see why it tops our ranking.
The bottom line for mothers
Best for: Readers who want the full price list up front and both a low-dose on-ramp and a genuine brand-name option from one provider, and who don't need to know which pharmacy is compounding it.
Alternatives to Luvo Health
Providers we have a referral relationship with, ordered by their Editors' Rating — highest first. A fee never moves a rating, but it does decide who appears here, so this is not the whole roster: the full ranking lists every provider we cover.
- Visit CoreAge RxCoreAge RxOur #1 pick
The one program on this masthead whose number still makes sense at the top of the dose. A flat, all-in monthly price on both molecules, no teaser rate to expire, and a cancel button you can actually find — the closest thing to a family-budget guarantee we've reviewed.
- Visit Gala Health
A flat $179 for either molecule and a genuinely gentle microdosing tier — a reasonable, all-doses-included option, if you can live with a yearly plan and a pharmacy the marketing never names.
- Visit Sesame
A high-trust telehealth marketplace that took a clear side: FDA-approved brand GLP-1 only, no compounded shortcut. You pay a brand cash price and book a real video visit — but you get on-label pens and one of the cleaner reputations on this masthead.
Keep comparing Luvo Health
Head-to-head & alternatives
Luvo Health, answered
- What does Luvo cost a month?
- Semaglutide injection is $249 and tirzepatide $339 on the four-week plan, with semaglutide tablets at $279. Twelve weeks brings those to about $219 and $309 a month. There's also a microdosing tier at $179 for either molecule, and genuine brand Ozempic at $1,299 and Zepbound at $1,399 if you want the on-label product. Luvo publishes all of it openly before you start, which is more than most.
- What is the microdosing tier?
- A low-dose version of either molecule at $179 a month, roughly half the standard tirzepatide price. It can be a gentler on-ramp, and Luvo prices it honestly rather than hiding it. But 'microdosing' is a marketing word rather than a proven protocol — think of it as a slower titration, not a safer category of GLP-1, and it is still not appropriate in pregnancy or while breastfeeding.
- Do they say which pharmacy fills it?
- No, and that is the clearest gap. Luvo says medication comes from 'licensed pharmacies' and never names one, which is a step behind providers that publish their compounding partner outright. It does display a LegitScript seal, and that one checks out — the seal ID returns a live image from LegitScript's own domain while an invented ID returns an error.
- What happens if I'm not approved?
- You aren't charged. Luvo states plainly that if you're not clinically eligible you won't be billed, and there's no commitment until a clinician reviews you. After that it's a subscription: you can pause or cancel from your account, but the change has to land before the next order starts processing, and refunds depend on whether a prescription has already been filled or shipped.
Pricing, states and verification reflect Luvo Health's public disclosures at last review; the Editors' Rating is our editorial judgment per the published methodology. This is background reading, not medical advice — GLP-1 medications are not established as safe in pregnancy or breastfeeding. See our medical disclaimer and how we're funded.